Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients
Aneta Cymbaluk-Płoska,1 Anita Chudecka-Głaz,1 Ewa Pius-Sadowska,2 Agnieszka Sompolska-Rzechuła,3 Bogusław Machaliński,2 Anna Surowiec,1 Janusz Menkiszak1 1Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, 2Department of General Pathology, Pomeranian Medical U...
Main Authors: | Cymbaluk-Ploska A, Chudecka-Głaz A, Pius-Sadowska E, Sompolska-Rzechuła A, Machaliński B, Surowiec A, Menkiszak J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-06-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/clinical-importance-of-serum-he4-and-mmp2-levels-in-endometrial-cancer-peer-reviewed-article-OTT |
Similar Items
-
Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer
by: Aneta Cymbaluk-Płoska, et al.
Published: (2018-01-01) -
Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer
by: Cymbaluk-Płoska A, et al.
Published: (2018-03-01) -
Circulating Serum Level of Visfatin in Patients with Endometrial Cancer
by: Aneta Cymbaluk-Płoska, et al.
Published: (2018-01-01) -
Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?
by: Aneta Cymbaluk-Płoska, et al.
Published: (2021-03-01) -
Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer
by: Aneta Cymbaluk-Płoska, et al.
Published: (2017-01-01)